These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 23455494)

  • 1. Chromobacterium violaceum: important insights for virulence and biotechnological potential by exoproteomic studies.
    Ciprandi A; da Silva WM; Santos AV; de Castro Pimenta AM; Carepo MS; Schneider MP; Azevedo V; Silva A
    Curr Microbiol; 2013 Jul; 67(1):100-6. PubMed ID: 23455494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of secreted virulence factors of Chromobacterium violaceum.
    Castro-Gomes T; Cardoso MS; DaRocha WD; Laibida LA; Nascimento AM; Zuccherato LW; Horta MF; Bemquerer MP; Teixeira SM
    J Microbiol; 2014 Apr; 52(4):350-3. PubMed ID: 24535738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of iron on the proteomic profile of Chromobacterium violaceum.
    Lima DC; Duarte FT; Medeiros VK; Lima DB; Carvalho PC; Bonatto D; Batistuzzo de Medeiros SR
    BMC Microbiol; 2014 Oct; 14():267. PubMed ID: 25361869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromobacterium pathogenicity island 1 type III secretion system is a major virulence determinant for Chromobacterium violaceum-induced cell death in hepatocytes.
    Miki T; Iguchi M; Akiba K; Hosono M; Sobue T; Danbara H; Okada N
    Mol Microbiol; 2010 Aug; 77(4):855-72. PubMed ID: 20545857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Virulence determinant of Chromobacterium violaceum].
    Miki T
    Nihon Saikingaku Zasshi; 2014; 69(4):577-88. PubMed ID: 25447983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Chromobacterium violaceum type III effector CopE, a guanine nucleotide exchange factor for Rac1 and Cdc42, is involved in bacterial invasion of epithelial cells and pathogenesis.
    Miki T; Akiba K; Iguchi M; Danbara H; Okada N
    Mol Microbiol; 2011 Jun; 80(5):1186-203. PubMed ID: 21435035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global Transcriptional Response to Organic Hydroperoxide and the Role of OhrR in the Control of Virulence Traits in Chromobacterium violaceum.
    Previato-Mello M; Meireles DA; Netto LES; da Silva Neto JF
    Infect Immun; 2017 Aug; 85(8):. PubMed ID: 28507067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ferric Uptake Regulator Fur Coordinates Siderophore Production and Defense against Iron Toxicity and Oxidative Stress and Contributes to Virulence in Chromobacterium violaceum.
    Santos RERS; Batista BB; da Silva Neto JF
    Appl Environ Microbiol; 2020 Oct; 86(21):. PubMed ID: 32859594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromobacterium violaceum genome: molecular mechanisms associated with pathogenicity.
    Brito CF; Carvalho CB; Santos F; Gazzinelli RT; Oliveira SC; Azevedo V; Teixeira SM
    Genet Mol Res; 2004 Mar; 3(1):148-61. PubMed ID: 15100995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromobacterium violaceum and its important metabolites--review.
    Durán M; Faljoni-Alario A; Durán N
    Folia Microbiol (Praha); 2010 Nov; 55(6):535-47. PubMed ID: 21253897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromobacterium violaceum: a review of pharmacological and industiral perspectives.
    Durán N; Menck CF
    Crit Rev Microbiol; 2001; 27(3):201-22. PubMed ID: 11596879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Chromobacterium violaceum genes with potential biotechnological application in environmental detoxification.
    Carepo MS; Azevedo JS; Porto JI; Bentes-Sousa AR; Batista Jda S; Silva AL; Schneider MP
    Genet Mol Res; 2004 Mar; 3(1):181-94. PubMed ID: 15100998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenicity of nonpigmented cultures of Chromobacterium violaceum.
    Sivendra R; Tan SH
    J Clin Microbiol; 1977 May; 5(5):514-6. PubMed ID: 874071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatal wound infection caused by Chromobacterium violaceum in Ho Chi Minh City, Vietnam.
    Baker S; Campbell JI; Stabler R; Nguyen HV; To DS; Nguyen DV; Farrar J
    J Clin Microbiol; 2008 Nov; 46(11):3853-5. PubMed ID: 18799697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phagocyte NADPH oxidase, but not inducible nitric oxide synthase, is essential for early control of Burkholderia cepacia and chromobacterium violaceum infection in mice.
    Segal BH; Ding L; Holland SM
    Infect Immun; 2003 Jan; 71(1):205-10. PubMed ID: 12496167
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Batista JH; da Silva Neto JF
    Front Microbiol; 2017; 8():2213. PubMed ID: 29176969
    [No Abstract]   [Full Text] [Related]  

  • 17. Genetic variability in isolates of Chromobacterium violaceum from pulmonary secretion, water, and soil.
    Santini AC; Magalhães JT; Cascardo JC; Corrêa RX
    Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromobacterium violaceum: a potential nosocomial pathogen.
    Umadevi S; Kumar S; Stephen S; Joseph NM
    Am J Infect Control; 2013 Apr; 41(4):386. PubMed ID: 23084472
    [No Abstract]   [Full Text] [Related]  

  • 19. Chromobacterium violaceum: a case of diarrhea in Senegal.
    Dromigny JA; Fall AL; Diouf S; Perrier-Gros-Claude JD
    Pediatr Infect Dis J; 2002 Jun; 21(6):573-4. PubMed ID: 12182388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromobacterium violaceum nosocomial pneumonia in two Japanese patients at an intensive care unit.
    Hagiya H; Murase T; Suzuki M; Shibayama K; Kokumai Y; Watanabe N; Maki M; Otsuka F
    J Infect Chemother; 2014 Feb; 20(2):139-42. PubMed ID: 24548644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.